ro 32-0432 has been researched along with aprinocarsen in 1 studies
| Studies (ro 32-0432) | Trials (ro 32-0432) | Recent Studies (post-2010) (ro 32-0432) | Studies (aprinocarsen) | Trials (aprinocarsen) | Recent Studies (post-2010) (aprinocarsen) |
|---|---|---|---|---|---|
| 56 | 0 | 13 | 31 | 7 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goekjian, PG; Jirousek, MR | 1 |
1 review(s) available for ro 32-0432 and aprinocarsen
| Article | Year |
|---|---|
Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development.
Topics: Azepines; Bryostatins; Carbazoles; Enzyme Inhibitors; Humans; Hydroxybenzoates; Indoles; Lactones; Macrolides; Maleimides; Oligodeoxyribonucleotides, Antisense; Protein Kinase C; Pyrroles; Signal Transduction; Thionucleotides | 1999 |